Global Sleep Apnea Diagnostic And Therapeutic Market Trends 2019-2027
                     GLOBAL SLEEP APNEA DIAGNOSTIC AND 
THERAPEUTIC MARKET
FORECAST 2019-2027

• The disorder of sleep apnea occurs when a patient’s 
breathing patterns during sleep decreases or pauses 
momentarily (called apnea) for 10 seconds or longer and it 
can occur 30 times or more in an hour.
• The global sleep apnea diagnostic and therapeutic market is 
anticipated to generate revenue of $9,986 million by 2027 
and will grow at an estimated CAGR of 6.72% between 2019 
and 2027. 
• Increase in the number of shift workers, the rising prevalence 
of sleep apnea and the technological advancements are 
mainly driving the market growth.
• Obesity is considered a major risk factor in the development 
and progression of sleep apnea. 
• The prevalence of sleep apnea in obese patients is almost 
two-fold higher than the normal case. Some of the factors 
that are expected to contribute to the sleeping disorders in 
the elderly population are retirements, various cognitive 
problems, excessive daytime sleepiness, and many more.
• The medical devices are specialized equipment that requires 
government approval for their sale. Obtaining approval can 
be a time-consuming and high-cost procedure, which can 
affect market growth. The need for R&D efforts and low heat 
resistance are the major factors hindering the sleep apnea 
diagnostic and therapeutic market. 

“The Global Sleep Apnea Diagnostic and Therapeutic Market is 
estimated to grow at a CAGR of 6.72% between 2019 and 2027.”
The 
North America market for sleep 
apnea diagnostic and therapeut
ic services
 are expected to proliferate at a 
CAGR of 6.00% during the 
forecasting years of 2019-2027.
The Europe Market for Sleep Apnea D
iagnostic and Therapeutic Market is 
proliferating at a CAGR of 6.15% 
during the forecasting years of 2019-
2027. 
The Asia Pacific Sleep Apnea D
iagnostic and Therapeutic Market is 
estimated to grow from $xx million in 
2018 to $xx million by 2027, at a CAGR 
of 8.67% between 2019 and 2027.
The major market players operating in the market are 
CareFusion (Merged With Becton Dickinson), Koninklijke 
Philips N.V. (Philips), Resmed Inc., Nihon Kohden 
Corporation, Medtronic PLC, Smiths Group PLC (Smiths 
Medical), Itamar Medical Ltd., Invacare Corp., Fisher & 
Paykel Healthcare, Drive Devilbiss Healthcare, Cadwell, 
GE Healthcare, Teleflex, Braebon Medical Corporation 
and Somnomedics. These market players follow several 
key developmental strategies and focus on launching 
innovative diagnosis products to cater to patient’s as 
well as medical professional’s requirements and to 
strengthen their market share.